Yan Xu is a certified molecular biologist and an expert in next-generation sequencing (NGS) and in vitro diagnostics (IVD). She has over five years of experience in leading and managing technology research and development projects in the field of oncology, from lab design and test validation to product innovation and optimization.As the Chief Technology Officer at TopGen, a biotechnology company based in Shanghai, China, she is responsible for overseeing the company's technology strategy and execution, solving technical problems, improving user experience, and collaborating with domestic and foreign experts. She is passionate about applying cutting-edge molecular and bioinformatics technologies to advance the diagnosis and treatment of various cancers, such as lung, colorectal, breast, ovarian, and liver cancers. She also attends academic conferences and makes presentations to share her insights and findings.